Clinical Trial Update: Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Ain Shams University assesses safety, tolerability, and efficacy of a single-dose low-cost minipool intravenous immunoglobulin in mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Ain Shams University | Conditions: Newly Diagnosed Pediatric ITP | Phase 2 | Status: UNKNOWN